Clinical Trials Logo

Clinical Trial Summary

The main purpose of the study is to find out 1. the natural course of refractory dermatitis herpetiformis and the development of possible complications 2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis


Clinical Trial Description

Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and prognosis of refractory celiac disease. Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05998291
Study type Observational [Patient Registry]
Source Tampere University Hospital
Contact
Status Enrolling by invitation
Phase
Start date June 15, 2023
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05597904 - Background of Different Phenotypes of Coeliac Disease
Terminated NCT01115244 - Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis Phase 4
Recruiting NCT01952275 - Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases N/A
Completed NCT00962182 - Study of Enzyme Supplements to Treat Celiac Disease Phase 1/Phase 2